In breast cancer, the highly homologous miR-221 and miR-222 promote cell proliferation through the EGFR (epidermal growth factor receptor)-Ras-Raf-MAPK/ERK (mitogen-activated/extracellular signal-regulated protein kinase) pathway [5]. This evidence concerns the gene EGFR and breast carcinoma.